Veeva Systems Cash Flow from Investing Activities 2012-2025 | VEEV

Veeva Systems annual/quarterly cash flow from investing activities history and growth rate from 2012 to 2025. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
  • Veeva Systems cash flow from investing activities for the quarter ending January 31, 2025 was $-0.700B, a 34.95% decline year-over-year.
  • Veeva Systems cash flow from investing activities for the twelve months ending January 31, 2025 was $-2.043B, a 37.7% decline year-over-year.
  • Veeva Systems annual cash flow from investing activities for 2025 was $-0.7B, a 34.95% decline from 2024.
  • Veeva Systems annual cash flow from investing activities for 2024 was $-1.076B, a 6.81% increase from 2023.
  • Veeva Systems annual cash flow from investing activities for 2023 was $-1.008B, a 191.11% increase from 2022.
Veeva Systems Annual Cash Flow Investing
(Millions of US $)
2025 $-700
2024 $-1,076
2023 $-1,008
2022 $-346
2021 $-334
2020 $-517
2019 $-104
2018 $-155
2017 $-97
2016 $-97
2015 $-272
2014 $-27
2013 $-16
2012 $-2
2011 $-1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $47.172B $2.747B
Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data).
Stock Name Country Market Cap PE Ratio
Hims & Hers Health (HIMS) United States $11.812B 122.72
Tempus AI (TEM) United States $10.155B 0.00
IRhythm Technologies (IRTC) United States $4.637B 0.00
Inspire Medical Systems (INSP) United States $4.007B 62.61
Hinge Health (HNGE) United States $3.004B 0.00
Privia Health (PRVA) United States $2.780B 190.00
Enovis (ENOV) United States $1.805B 10.06
Schrodinger (SDGR) United States $1.749B 0.00
Clover Health Investments (CLOV) United States $1.537B 0.00
Phreesia (PHR) United States $1.534B 0.00
Omnicell (OMCL) United States $1.446B 25.51
Azenta (AZTA) United States $1.296B 60.21
10x Genomics (TXG) United States $1.122B 0.00
Fulgent Genetics (FLGT) United States $0.634B 0.00
Claritev (CTEV) United States $0.631B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.544B 162.50
Veradigm (MDRX) United States $0.487B 0.00
Standard BioTools (LAB) United States $0.378B 0.00
Outset Medical (OM) United States $0.356B 0.00
TruBridge (TBRG) United States $0.353B 784.00
Health Catalyst (HCAT) United States $0.267B 0.00
Nyxoah SA (NYXH) Belgium $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.135B 0.00
EUDA Health Holdings (EUDA) Singapore $0.124B 0.00
Pulmonx (LUNG) United States $0.120B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.091B 3.48
111 (YI) China $0.072B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00